Biontech stock

biontech stock

What is the price target for biontech stock?

Their forecasts range from $146.00 to $433.00. On average, they expect BioNTechs stock price to reach $292.15 in the next year. This suggests a possible upside of 35.3% from the stocks current price. View analysts price targets for BioNTech or view top-rated stocks among Wall Street analysts. Who are BioNTechs key executives?

Where can I buy biontech (bntx)?

Shares of BNTX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is BioNTechs stock price today?

Who are biontechs major shareholders?

BioNTech trades on the NASDAQ under the ticker symbol BNTX. Who are BioNTechs major shareholders? BioNTechs stock is owned by a number of institutional and retail investors. Top institutional investors include Magnolia Capital Management Ltd. (0.00%), Carroll Financial Associates Inc. (0.00%) and Harbor Investment Advisory LLC (0.00%).

What does biontech se do?

Sign-up to receive the latest news and ratings for BioNTech and its competitors with MarketBeats FREE daily newsletter. BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases.

What are analystsprice targets for biontechs stock?

13 analysts have issued twelve-month price targets for BioNTechs shares. Their forecasts range from $146.00 to $433.00. On average, they expect BioNTechs stock price to reach $292.15 in the next year.

Is biontech stock a buy or sell?

Analysts rate BioNTech a consensus ‘hold’, with five ‘buy’ ratings, seven ‘hold’ ratings and one ‘sell’ rating, according to MarketBeat . BioNTech stock price predictions for the next twelve month period range from a low of $126 to a high of $433.

What will biontech (bntx) stock price be in 2021?

BioNTech (BNTX) stock Forecast for 2021, 2022, 2023, 2024, 2025. What analysts predict:: $315.13 This figure corresponds to the average price over the previous 50/200 days. For BioNTech stocks, the 50-day moving average is the resistance level today. For BioNTech stocks, the 200-day moving average is the support level today.

Does biontech have an upside of 15%?

According to analysts, BioNTechs stock has a predicted upside of 15.30% based on their 12-month price targets. What analysts cover BioNTech?

BioNTechs address is: An der Goldgrube 12, Mainz, Germany, 55131 What is BioNTechs ISIN number? BioNTechs international securities identification number is: US09075V1026 What is BioNTechs CUSIP number?

What does biontechs beta mean?

Who is biontech owned by?

Who owns BioNTech? Based in Mainz, Germany, BioNTech is listed on the US stock exchange. Like Pfizer its owners are predominantly mutual funds and other institutional stakeholders, with the largest shareholder owning under 1% of the company. The top ten shareholders are as follows, according to CNN:

Who is the richest biotech investor in the world?

Hopp, who Forbes estimates to be worth $13.4 billion, has become a significant biotech investor. He said in an interview with the German publication Handelsblatt that he has put over $1.5 billion into biotech firms. CureVac is worth $1.7 billion, according to CB Insights.

Who owns CureVac and biontech?

One of Germany’s wealthiest software tycoons is the biggest shareholder in CureVac, a company racing to develop a coronavirus vaccine. Two German billionaire biotech investors are also behind BioNTech, which announced Monday it’s developing a vaccine.

Who are the major shareholders of a company?

Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds (or held) more than 5% of the company and intends (or intended) to actively pursue a change in business strategy.

Postagens relacionadas: